Member Login
  1. Stocks
    2. /
  2. GSK (LSE: GSK)
    3. /

LSE:GSK (GSK)

About GSK

GlaxoSmithKline is one of the worlds leading pharmaceutical research companies. The company was created out of the merger between GlaxoWellcome and SmithKline Beecham in 2000.
Financial Market Data copyright © 2024 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • GSK (LSE: GSK) Latest News

    Mixed-race female couple enjoying themselves on a walk
    Investing Articles

    Are these 2 FTSE 100 stocks among the best shares to buy today?

    | Zaven Boyrazian, MSc

    These two FTSE 100 stocks are making strides to deliver growth, yet their share prices remain depressed. Is this a…

    Read more »

    A GlaxoSmithKline scientist uses a microscope
    Investing Articles

    Will GSK’s share price spike on Zantac news be sustained?

    | Simon Watkins

    GSK’s share price spiked on news of a settlement over Zantac, but other factors also mean it may continue to…

    Read more »

    Syringe and vial on blue background
    Investing Articles

    3 reasons to buy GSK shares right now?

    | Alan Oscroft

    GSK shares are on a fairly modest valuation at the moment, even though City forecasts for profits and dividends are…

    Read more »

    A GlaxoSmithKline scientist uses a microscope
    Investing Articles

    Down 12% since April, the GSK share price fall looks overdone to me

    | Simon Watkins

    With a raft of new products, healthy dividends and growth prospects, the almost 12% fall in the GSK share price…

    Read more »

    The words "what's your plan for retirement" written on chalkboard on pavement somewhere in London
    Investing Articles

    4,950 abrdn shares and 716 GSK shares would give me £1,100 annual passive income

    | Harvey Jones

    Investing my £20,000 ISA allowance in these two FTSE 100 stocks should generate plenty of passive income, but should I…

    Read more »

    Young woman holding up three fingers
    Investing Articles

    3 FTSE 100 stocks I don’t think will stay cheap for long

    | John Fieldsend

    The FTSE 100’s lack of growth in recent years has led to some stocks looking curiously undervalued. Here are my…

    Read more »

    Young Black woman looking concerned while in front of her laptop
    Investing Articles

    If I’d invested £5k in GSK shares one year ago here’s what I’d have today

    | Harvey Jones

    GSK shares have disappointed lately, but today's low valuation and rising yield could make now the perfect time to buy.

    Read more »

    A GlaxoSmithKline scientist uses a microscope
    Investing Articles

    I’d buy 886 GSK shares for £500 a year in passive income

    | Charlie Carman

    GSK shares already feature in our writer's passive income portfolio. He plans to buy more to boost his annual dividend…

    Read more »

    Smiling family of four enjoying breakfast at sunrise while camping
    Investing Articles

    3 FTSE 100 and FTSE 250 value stocks I’d buy right now

    | Royston Wild

    The London Stock Exchange is packed with top value stocks offering low earnings multiples and big dividend yields. These three…

    Read more »

    Man writing 'now' having crossed out 'later', 'tomorrow' and 'next week'
    Investing Articles

    Is the GSK share price going higher — or nowhere?

    | Cliff D'Arcy

    The GSK share price has dropped nearly 6% since its 2023 high earlier in April. With things looking up for…

    Read more »

    Young black man looking at phone while on the London Overground
    Investing Articles

    Here’s the GSK dividend forecast for 2023 and 2024!

    | Royston Wild

    The GSK share price offers solid all-round value for money right now. Should investors buy the FTSE firm based on…

    Read more »

    A GlaxoSmithKline scientist uses a microscope
    Investing Articles

    Is this star FTSE 100 stock set for take-off after Q1 results surprise?

    | Simon Watkins

    GSK is a star FTSE 100 stock whose price has fallen over 15% in the past year, but its Q1…

    Read more »